The article discusses the challenges and opportunities in targeting metastasis, the process by which cancer cells spread from a primary site to distant organs. Metastasis is a major cause of cancer-related deaths, and current therapies often focus on the initial tumor growth rather than the metastatic process. The review highlights the need for new therapeutic strategies that target the metastatic microenvironment, including interactions with the immune system, extracellular matrix, and signaling pathways that promote survival and proliferation of cancer cells. It also discusses the limitations of current therapies, such as the lack of effective drugs targeting metastasis and the difficulty in validating these therapies in clinical trials. The review emphasizes the importance of understanding the molecular mechanisms of metastasis, including genomic instability, and the role of various signaling pathways in promoting metastatic colonization. It also discusses the potential of targeting specific pathways, such as those involved in angiogenesis, immune evasion, and cell adhesion, to prevent or treat metastasis. The review concludes that while there is growing interest in developing therapies that target metastasis, there are still significant challenges in translating these findings into effective clinical treatments. The article also highlights the importance of preclinical models in evaluating the efficacy of metastasis-targeting therapies and the need for more accurate and relevant models to better understand the complex biology of metastasis.The article discusses the challenges and opportunities in targeting metastasis, the process by which cancer cells spread from a primary site to distant organs. Metastasis is a major cause of cancer-related deaths, and current therapies often focus on the initial tumor growth rather than the metastatic process. The review highlights the need for new therapeutic strategies that target the metastatic microenvironment, including interactions with the immune system, extracellular matrix, and signaling pathways that promote survival and proliferation of cancer cells. It also discusses the limitations of current therapies, such as the lack of effective drugs targeting metastasis and the difficulty in validating these therapies in clinical trials. The review emphasizes the importance of understanding the molecular mechanisms of metastasis, including genomic instability, and the role of various signaling pathways in promoting metastatic colonization. It also discusses the potential of targeting specific pathways, such as those involved in angiogenesis, immune evasion, and cell adhesion, to prevent or treat metastasis. The review concludes that while there is growing interest in developing therapies that target metastasis, there are still significant challenges in translating these findings into effective clinical treatments. The article also highlights the importance of preclinical models in evaluating the efficacy of metastasis-targeting therapies and the need for more accurate and relevant models to better understand the complex biology of metastasis.